Want to join the conversation?
$BXLT said the Japan's Ministry of Health, Labour and Welfare has approved ADYNOVATE, an extended circulating half-life recombinant Factor VIII treatment, for patients 12 years and older with hemophilia A. ADYNOVATE leverages pegylation technology reducing the speed at which it is cleared from the blood, thus resulting in increased half-life.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?